Best Penile Cancer Doctors in Hyderabad — CION's Dedicated Penile Cancer Panel

The best doctor for penile cancer is a surgical oncologist with experience in organ-preserving surgery and inguinal lymphadenectomy, paired with a radiation oncologist (for radiation as an alternative organ-preservation approach) and a medical oncologist (for advanced disease). For complex organ-preserving reconstructions, uro-oncology subspecialty input is valuable. At CION, every penile cancer case is reviewed by a multidisciplinary tumour board, with surgical leadership by Dr. Vinay Mamidala (M.Ch Surgical Oncology, FMAS) — and advanced reconstructive techniques coordinated through accredited partner uro-oncology and reconstructive teams where indicated.

Yes — for most early-stage and many intermediate-stage penile cancers, penile preservation is now the recommended approach. The 2024 European Association of Urology (EAU) Guidelines on Penile Cancer state that penile-preserving treatment is the primary surgical approach for localised disease, based on equivalent oncological outcomes (around 82–84% 5-year recurrence-free survival) compared to partial or total penectomy. Modern 5-mm surgical margins make organ-sparing surgery oncologically safe. Options include topical chemotherapy (5-FU, imiquimod) for very early in-situ disease, laser ablation, wide local excision, partial glansectomy, and glansectomy with neoglans reconstruction. Partial penectomy is reserved for tumours involving the corpora cavernosa, and total penectomy for advanced cases where organ preservation is not possible. CION's surgical oncology team performs organ-preserving surgery directly, with advanced reconstructive techniques coordinated through accredited partner uro-oncology and reconstructive teams where indicated. The first conversation should always be about whether your specific case is suitable for preservation.

Inguinal lymph node management is one of the most important and nuanced decisions in penile cancer. The lymph nodes in the groin (inguinal nodes) are the first site of spread. Three approaches exist: (1) surveillance (close monitoring) for very low-risk early-stage disease, (2) sentinel lymph node biopsy (SLNB) — a minimally invasive technique that samples the first-draining nodes for intermediate-risk cases, and (3) full inguinal lymphadenectomy for clinically positive nodes or high-risk tumours. Full lymphadenectomy has significant morbidity — lymphedema (leg swelling), wound complications, infection — so it should be reserved for cases where it's truly needed. Centres that default to either always doing full dissection or never doing any nodal assessment may be missing the appropriate approach. CION's tumour board reviews each case individually to determine the right nodal strategy. Dr. Mamidala's FMAS training enables minimally invasive approaches where appropriate.

Both — but in the right order. A general urologist usually evaluates the initial lesion and performs the biopsy that confirms cancer. From there, treatment is best led by a surgical oncologist or uro-oncologist with specific experience in penile cancer surgery and inguinal lymphadenectomy. For radiation as an alternative organ-preserving approach, a radiation oncologist. For advanced or metastatic disease, a medical oncologist for the TIP chemotherapy regimen (paclitaxel, ifosfamide, cisplatin). A general surgeon performing penile cancer surgery without surgical oncology or uro-oncology training has meaningfully different outcomes.

Approximately 30–50% of penile cancers are caused by human papillomavirus (HPV) — most commonly HPV-16. HPV is a common virus, and most people clear infections without ever developing cancer; in a subset, persistent infection causes cellular changes that may progress to cancer over years. Other major risk factors include phimosis (inability to retract the foreskin — which allows chronic irritation and infection buildup), poor genital hygiene, lichen sclerosus, smoking, HIV/immunosuppression, and chronic balanitis. These factors often coexist. HPV vaccination, given before exposure, can reduce risk for future generations. This is not a reflection on you or your behaviour, and modern oncology consultations are confidential and non-judgemental.

Most penile cancer patients delay seeking care due to embarrassment — and we understand. But delay is common, not a reason to delay further. Even with delayed presentation, modern treatment has options for most stages. The most important step is the next one: a consultation, biopsy, and staging. Whether your case is suitable for organ preservation depends on the current extent of disease, which we can only assess with proper evaluation. CION consultations are confidential, non-judgemental, and focused entirely on getting you the right treatment as quickly as possible from where you are now. Telugu, Hindi, and English available.

It depends on the extent of treatment. With organ-preserving surgery for early-stage disease, urinary function is generally preserved with normal standing urination, and sexual function is largely preserved (with some sensory changes possible). After partial penectomy, a functional penile stump is reconstructed to allow standing urination; sexual function may be reduced but is often possible depending on the length of remaining tissue. Total penectomy with perineal urethrostomy allows urination from a perineal opening (often requiring a sitting position) and ends penetrative sexual function. The full impact on quality of life is a critical part of the consultation and should be discussed openly before treatment begins.

For penile cancer that has spread to inguinal or pelvic lymph nodes, treatment includes neoadjuvant chemotherapy (typically TIP — paclitaxel, ifosfamide, cisplatin) followed by surgery, or chemoradiation. For metastatic disease, chemotherapy is the primary approach with palliative radiation for symptom control where needed. Immunotherapy is being studied in trials for penile cancer but is not yet standard of care. CION's medical oncology team delivers the TIP regimen and coordinates the multidisciplinary plan for advanced cases.

A second opinion is especially valuable for penile cancer — particularly if you've been offered upfront partial or total penectomy without organ-preserving options being seriously discussed, which may not be current standard of care for localised disease. At CION the second opinion is free, written, and yours to keep — our multidisciplinary tumour board reviews your biopsy, imaging, and existing recommendation and provides a documented opinion you can take anywhere.

Costs vary by stage and approach. Organ-preserving surgery (wide local excision, partial glansectomy) ranges approximately ₹80,000 to ₹2,00,000; partial penectomy ranges ₹1,50,000 to ₹3,50,000; total penectomy with perineal urethrostomy ranges ₹2,50,000 to ₹5,00,000+; inguinal lymphadenectomy adds ₹1,00,000 to ₹2,50,000 depending on extent. TIP chemotherapy ranges ₹1,50,000 to ₹4,00,000+ over multiple cycles. For a detailed cost breakdown by treatment type, see our penile cancer treatment in Hyderabad page. Every CION patient receives a written, itemised cost estimate before treatment begins. Aarogyasri, EMI, and cashless insurance are accepted.